Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. 2012

Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069439 Dasatinib A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,BMS 354825,BMS-354825,BMS354825,N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide,Sprycel,354825, BMS

Related Publications

Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
August 2013, Annals of hematology,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
August 2023, International journal of hematology,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
October 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
December 2009, Pediatric blood & cancer,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
October 2010, International journal of hematology,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
June 2005, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
January 2014, SpringerPlus,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
January 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
January 2020, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Giovanni Caocci, and Adriana Vacca, and Antonio Ledda, and Francesca Murgia, and Eugenia Piras, and Marianna Greco, and Marcella Arras, and Sandra Atzeni, and Roberto Littera, and Giorgio La Nasa
February 2010, Zhongguo shi yan xue ye xue za zhi,
Copied contents to your clipboard!